$PHIO·4

RXi Pharmaceuticals Corp · Jun 3, 8:04 AM ET

RXi Pharmaceuticals Corp 4

4 · RXi Pharmaceuticals Corp · Filed Jun 3, 2015

Insider Transaction Report

Form 4
Period: 2015-06-02
Pavco Pamela
Chief Development Officer
Transactions
  • Award

    Overallotment purchase right

    2015-06-02+6,2506,250 total
    Exercise: $0.46From: 2015-06-02Exp: 2016-07-02Common stock (6,250 underlying)
  • Award

    Common stock, $0.0001 par value

    2015-06-02$0.40/sh+12,500$5,00033,718 total
  • Award

    Common stock purchase warrant

    2015-06-02+6,2506,250 total
    Exercise: $0.52From: 2015-06-02Exp: 2020-06-02Common stock (6,250 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION